Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Peginterferon alfa-2b for Pediatric RSV Bronchiolitis
NCT06827249Recruiting
- Sponsor
- Children's Hospital of Soochow University
- Start
- Mar 2025
- Primary completion
- Jun 2026
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
Randomised trial of peginterferon alfa-2b in respiratory syncytial virus bronchiolitis (2 arms), sponsored by Children's Hospital of Soochow University. Primary endpoint: The rate of change in Wang's bronchiolitis score from baseline at Day 6. Started Mar 2025; status: recruiting.
02
Drugs
peginterferon alfa-2b
03
Conditions
respiratory syncytial virus bronchiolitis
Beyond the preview
Go deeper on NCT06827249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06827249.